Sensitivity analysis demonstrated that no single study could influence the statistically significant differences in CSF YKL-40 levels between AD patients and controls, and CSF MCP-1 levels between ALS patients and controls. The gene discussed is CHI3L1; the disease is Alzheimer disease.